The U.S. economy defied worries of recession for the past three years and experienced surprisingly stellar growth. But don't expect a repeat in 2025: Weak or worse are the are only two paths for the ...

The 30-year yield gained 0.482 percentage points, its largest one-week gain since 1987, according to Dow Jones Market Data.

The carnage in the stock market following President Donald Trump's April 2 unveiling of sweeping tariffs on virtually all U.S. trade partners has been extraordinary - but it's a historic surge in long ...

As the biopharma industry grapples with the uncertain macro environment brought on by the new administration, CEOs, ...

The economy and the markets are "under surveillance" as we cover the latest in finance, economics and investment.

It’s unclear whether tariffs will influence more companies to make more drugs in the U.S. like President Donald Trump is ...

The president is expected to impose tariffs on pharmaceuticals, though full details of the plan have not yet been announced.

The S&P 500 (SP500) has faced a rocky start in 2025 which has prompted BMO Capital Markets to lower its year-end target for ...

Trump said he would announce pharmaceutical tariffs, as he increased tariffs on China to 125% and paused tariffs for 75 ...

U.S. corporate bond market issuances have dried up after opening for just one bond offering on Tuesday, as spreads in the ...

BMO Capital on Wednesday cut its year-end 2025 S&P 500 target by 9% to 6,100 from the prior 6,700, citing the speed and severity of the recent selloff.

Bank of Montreal has struggled as of late. Check out why I think that BMO's recent underperformance presents a buying ...